Abstract

Background:Interstitial lung disease (ILD) is the second leading cause of mortality in patients with rheumatoid arthritis (RA) (1). However, is frequently underrecognized as presents a highly variable clinical course, ranging...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call